{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:29:48Z","timestamp":1770740988038,"version":"3.49.0"},"reference-count":30,"publisher":"American Diabetes Association","issue":"11","license":[{"start":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T00:00:00Z","timestamp":1476921600000},"content-version":"vor","delay-in-days":56,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,11,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>A common nonsense mutation in TBC1D4 was recently found to substantially increase the odds of type 2 diabetes in Greenlandic Inuit, leading to exclusively increased postprandial glucose. We investigated the frequency and effect of the TBC1D4 mutation on glucose metabolism and type 2 diabetes diagnosis among Canadian and Alaskan Inuit.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>Exome sequencing of the TBC1D4 variant was performed in 114 Inuit from Nunavik, Canada, and Sanger sequencing was undertaken in 1,027 Alaskan Inuit from the Genetics of Coronary Artery Disease in Alaskan Natives (GOCADAN) Study. Association testing evaluated the effect of the TBC1D4 variant on diabetes-related metabolic traits and diagnosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>The TBC1D4 mutation was present in 27% of Canadian and Alaskan Inuit. It was strongly associated with higher glucose (effect size +3.3 mmol\/L; P = 2.5 x 10\u22126) and insulin (effect size +175 pmol\/L; P = 0.04) 2 h after an oral glucose load in homozygote carriers. TBC1D4 carriers with prediabetes and type 2 diabetes had an increased risk of remaining undiagnosed unless postprandial glucose values were tested (odds ratio 5.4 [95% CI 2.5\u201312]) compared with noncarriers. Of carriers with prediabetes or type 2 diabetes, 32% would remain undiagnosed without an oral glucose tolerance test (OGTT).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Disruption of TBC1D4 is common among North American Inuit, resulting in exclusively elevated postprandial glucose. This leads to underdiagnosis of type 2 diabetes, unless an OGTT is performed. Accounting for genetic factors in the care of Inuit with diabetes provides an opportunity to implement precision medicine in this population.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc16-0769","type":"journal-article","created":{"date-parts":[[2016,8,26]],"date-time":"2016-08-26T02:19:48Z","timestamp":1472177988000},"page":"1889-1895","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":47,"title":["Toward Precision Medicine: <i>TBC1D4<\/i> Disruption Is Common Among the Inuit and Leads to Underdiagnosis of Type 2 Diabetes"],"prefix":"10.2337","volume":"39","author":[{"given":"Despoina","family":"Manousaki","sequence":"first","affiliation":[{"name":"Centre for Clinical Epidemiology, Department of Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Quebec, Canada"},{"name":"Department of Human Genetics, McGill University, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Jack W.","family":"Kent","sequence":"additional","affiliation":[{"name":"Texas Biomedical Research Institute, San Antonio, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Haack","sequence":"additional","affiliation":[{"name":"Texas Biomedical Research Institute, San Antonio, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirui","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Medicine, McGill University, Montreal, Quebec, Canada"},{"name":"Department of Medicine, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingxing","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Medicine, McGill University, Montreal, Quebec, Canada"},{"name":"Montreal Neurological Institute and Hospital, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia M.","family":"Greenwood","sequence":"additional","affiliation":[{"name":"Centre for Clinical Epidemiology, Department of Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Quebec, Canada"},{"name":"Department of Human Genetics, McGill University, Montreal, Quebec, Canada"},{"name":"Department of Oncology, McGill University, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Brassard","sequence":"additional","affiliation":[{"name":"Centre for Clinical Epidemiology, Department of Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Quebec, Canada"},{"name":"Department of Medicine, McGill University, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah E.","family":"Newman","sequence":"additional","affiliation":[{"name":"Texas Biomedical Research Institute, San Antonio, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley","family":"Cole","sequence":"additional","affiliation":[{"name":"Texas Biomedical Research Institute, San Antonio, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason G.","family":"Umans","sequence":"additional","affiliation":[{"name":"MedStar Health Research Institute, Hyattsville, MD"},{"name":"Georgetown-Howard Universities Center for Clinical and Translational Science, Washington,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Rouleau","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, McGill University, Montreal, Quebec, Canada"},{"name":"Montreal Neurological Institute and Hospital, Montreal, Quebec, Canada"},{"name":"Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony G.","family":"Comuzzie","sequence":"additional","affiliation":[{"name":"Texas Biomedical Research Institute, San Antonio, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Brent","family":"Richards","sequence":"additional","affiliation":[{"name":"Centre for Clinical Epidemiology, Department of Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Quebec, Canada"},{"name":"Department of Human Genetics, McGill University, Montreal, Quebec, Canada"},{"name":"Department of Medicine, McGill University, Montreal, Quebec, Canada"},{"name":"Department of Twin Research and Genetic Epidemiology, King\u2019s College London, London, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2016,8,25]]},"reference":[{"key":"2022031301100432200_B1"},{"key":"2022031301100432200_B2","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMp1500523","article-title":"A new initiative on precision medicine","volume":"372","author":"Collins","year":"2015","journal-title":"N Engl J Med"},{"key":"2022031301100432200_B3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nature13425","article-title":"A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes","volume":"512","author":"Moltke","year":"2014","journal-title":"Nature"},{"key":"2022031301100432200_B4","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.2337\/diacare.25.10.1766","article-title":"Diabetes and impaired glucose tolerance among the inuit population of Greenland","volume":"25","author":"J\u00f8rgensen","year":"2002","journal-title":"Diabetes Care"},{"key":"2022031301100432200_B5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ajpa.20313","article-title":"mtDNA variation in Inuit populations of Greenland and Canada: migration history and population structure","volume":"130","author":"Helgason","year":"2006","journal-title":"Am J Phys Anthropol"},{"key":"2022031301100432200_B6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3402\/ijch.v64i3.17985","article-title":"A genetic and epidemiologic study of cardiovascular disease in Alaska natives (GOCADAN): design and methods","volume":"64","author":"Howard","year":"2005","journal-title":"Int J Circumpolar Health"},{"key":"2022031301100432200_B7","doi-asserted-by":"crossref","first-page":"e0128255","DOI":"10.1371\/journal.pone.0128255","article-title":"Increased missense mutation burden of fatty acid metabolism related genes in Nunavik Inuit population","volume":"10","author":"Zhou","year":"2015","journal-title":"PLoS One"},{"key":"2022031301100432200_B8","first-page":"1061","article-title":"A map of human genome variation from population-scale sequencing [published correction appears in Nature 2011;473:544]","volume":"467","author":"Abecasis","year":"2010","journal-title":"Nature"},{"key":"2022031301100432200_B9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0168-8227(99)00116-3","article-title":"Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures","volume":"47","author":"Gutt","year":"2000","journal-title":"Diabetes Res Clin Pract"},{"key":"2022031301100432200_B10","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1353\/hub.2006.0003","article-title":"Quantitative trait nucleotide analysis using Bayesian model selection","volume":"77","author":"Blangero","year":"2005","journal-title":"Hum Biol"},{"key":"2022031301100432200_B11","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1086\/301844","article-title":"Multipoint quantitative-trait linkage analysis in general pedigrees","volume":"62","author":"Almasy","year":"1998","journal-title":"Am J Hum Genet"},{"key":"2022031301100432200_B12","first-page":"189","article-title":"Why we (usually) don\u2019t have to worry about multiple comparisons","volume":"5","author":"Gelman","year":"2012","journal-title":"J Res Educ Eff"},{"key":"2022031301100432200_B13","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc10-S062","article-title":"Diagnosis and classification of diabetes mellitus","volume":"33","author":"American Diabetes Association","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031301100432200_B14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/03610928608829128","article-title":"A hybrid algorithm for Fishers exact test in unordered rxc contingency-tables","volume":"15","author":"Mehta","year":"1986","journal-title":"Commun Stat Theory Methods"},{"key":"2022031301100432200_B15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1145\/168173.168412","article-title":"A remark on algorithm-643 - Fexact - an algorithm for performing Fishers exact test in R X C contingency-tables","volume":"19","author":"Clarkson","year":"1993","journal-title":"ACM Trans Math Software"},{"key":"2022031301100432200_B16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1472-6963-9-41","article-title":"Trends in laboratory testing for diabetes in Ontario, Canada 1995\u20132005: a population-based study","volume":"9","author":"Wilson","year":"2009","journal-title":"BMC Health Serv Res"},{"key":"2022031301100432200_B17","doi-asserted-by":"crossref","first-page":"14599","DOI":"10.1074\/jbc.C300063200","article-title":"Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation","volume":"278","author":"Sano","year":"2003","journal-title":"J Biol Chem"},{"key":"2022031301100432200_B18","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1042\/BJ20120702","article-title":"AS160 deficiency causes whole-body insulin resistance via composite effects in multiple tissues","volume":"449","author":"Wang","year":"2013","journal-title":"Biochem J"},{"key":"2022031301100432200_B19","doi-asserted-by":"crossref","first-page":"9350","DOI":"10.1073\/pnas.0900909106","article-title":"A truncation mutation in TBC1D4 in a family with acanthosis nigricans and postprandial hyperinsulinemia","volume":"106","author":"Dash","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022031301100432200_B20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2337\/diacare.26.1.61","article-title":"Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts","volume":"26","author":"DECODE Study Group","year":"2003","journal-title":"Diabetes Care"},{"key":"2022031301100432200_B21","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.2337\/diacare.28.11.2626","article-title":"The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature","volume":"28","author":"Sorkin","year":"2005","journal-title":"Diabetes Care"},{"key":"2022031301100432200_B22","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.2337\/dc10-2414","article-title":"Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study","volume":"34","author":"Cavalot","year":"2011","journal-title":"Diabetes Care"},{"key":"2022031301100432200_B23","first-page":"2215","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies [published correction appears in Lancet 2010;376:958]","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"key":"2022031301100432200_B24","first-page":"S10","article-title":"Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada","volume":"27(Suppl. 2)","author":"Canadian Diabetes Association Clinical Practice Guidelines Expert Committee","year":"2003","journal-title":"Can J Diabetes"},{"key":"2022031301100432200_B25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00125-005-0071-9","article-title":"Diabetes mellitus and impaired fasting glucose in Alaska Eskimos: the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study","volume":"49","author":"Carter","year":"2006","journal-title":"Diabetologia"},{"key":"2022031301100432200_B26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.24095\/hpcdp.33.1.07","article-title":"Report summary. Diabetes in Canada: facts and figures from a public health perspective","volume":"33","author":"Pelletier","year":"2012","journal-title":"Chronic Dis Inj Can"},{"key":"2022031301100432200_B27","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1463-1326.2010.01244.x","article-title":"Screening for type 2 diabetes: an update of the evidence","volume":"12","author":"Simmons","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"2022031301100432200_B28","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/jmedgenet-2014-102934","article-title":"A homozygous PMS2 founder mutation with an attenuated constitutional mismatch repair deficiency phenotype","volume":"52","author":"Li","year":"2015","journal-title":"J Med Genet"},{"key":"2022031301100432200_B29","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.2217\/pgs.14.162","article-title":"Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors","volume":"15","author":"Della-Morte","year":"2014","journal-title":"Pharmacogenomics"},{"key":"2022031301100432200_B30","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cmet.2014.08.005","article-title":"Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes","volume":"20","author":"Soccio","year":"2014","journal-title":"Cell Metab"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/39\/11\/1889\/545433\/dc160769.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/39\/11\/1889\/545433\/dc160769.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T04:49:08Z","timestamp":1647146948000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/39\/11\/1889\/37286\/Toward-Precision-Medicine-TBC1D4-Disruption-Is"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,25]]},"references-count":30,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,8,25]]},"published-print":{"date-parts":[[2016,11,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc16-0769","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,25]]}}}